The MRC Clinical Trials Unit (MRC CTU) at UCL is at the forefront of resolving internationally important questions in infectious diseases and cancer, and delivering swifter and more effective translation of scientific research into patient benefits.
ICON8 trial shows having chemotherapy every week is no better than having it every three weeks for ovarian cancer
ICON8 was a large international trial looking at whether having smaller doses of chemotherapy more often could help women with epithelial ovarian, fallopian tube, or primary peritoneal cancer. These women are usually tre…
02 Dec
Join our RADICALS and ARTISTIC Twitter Q&A #ProstateRadiotherapy
On Thursday 28 November 2019, we'll be running a Twitter Q&A session about the RADICALS trial and the ARTISTIC meta-analysis - with the hashtag #ProstateRadiotherapy.
21 Nov
The 50th Union World Conference on Lung Health
MRC Clinical Trials Unit at UCL will be presenting results from the STREAM tuberculosis trial.
30 Oct
STAMPEDE provides further insight into treating prostate cancer
Further results from the STAMPEDE trial have been presented at European Society for Medical Oncology Congress 2019 over the last few days
30 Sep
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Great to see that our PROMIS, STAMPEDE and STOPCaP findings are changing how many with #prostatecancer are treated in England & Wales https://t.co/8H6v8YSHXL
RT @chivaprojects: Have you read the results of the AALPHI HIV study by @MRCCTU @ucl? You can find the NEW information flyer, & video her…
RT @uclnews: A huge congratulations to members of @ucl's community who have been recognised in the 2020 New Year’s Honours, including Prof…